Hindustan Foods Ltd Q2 FY2026 Concall Summary

Key Takeaways

• Quarterly revenue crossed INR1,000 crores for the first time, a milestone management calls defining, driven by diversification, new customer additions, and M&A.
• The shoe business has turned the corner: the division delivered its highest-ever quarterly revenue of INR133 crores, is now PAT-positive, and both North and South units have stabilized.
• Capex is running ahead of plan due to two bolt-on acquisitions (cone facility and HPC facility), and another INR550 crores-plus of capacity is advancing toward commissioning.
• Top-line growth trails capex growth by design: many large contracts are job-work arrangements where only conversion costs book as revenue, so PAT and EBITDA are the truer measures of asset sweating.
• What to watch next quarter: whether the Nashik ice cream facility reaches full capacity by Q4 as guided, the Panipat facility begins commercial production on schedule, and any quantified multi-year plan materializes from the "early next year" promise.

The INR1,000 Crore Quarter: What Drove It

• Four-year transformation compressed into one milestone: the company crossed INR1,000 crores quarterly revenue for the first time, a result of strategic diversification into foods and beverages, ice creams, healthcare and footwear, each now a sizable business despite being new entries.
• Customer base widened: new-age brands were added alongside larger incumbent FMCG players, while the business model deliberately shifted from predominantly dedicated manufacturing toward shared manufacturing to serve a changing FMCG ecosystem and improve returns.
• Profit expansion levers: better capacity utilization, operating leverage, and continuous focus on execution excellence drove the quarter's profit improvement.
• Cash flow strengthened materially: net cash flow from operations rose nearly 50% to approximately INR109 crores, reflecting healthy internal accruals and disciplined working capital management, aided by stabilization of the shoe business.

Sameer Kothari: "This quarter marks a defining moment in our journey. HFL crossed the INR1,000 crores quarterly revenue mark for the first time in its history. More than a financial milestone, it reflects the scale of transformation we have achieved and the acceleration with which we have grown over the last 4 years."

Shoe Business: The Turnaround Story

• Highest-ever quarterly revenue: the shoes division delivered INR133 crores, with both the North and South units now stabilized in quality and production after a loss-making prior year.
• Profitability restored: the business is now PAT-positive, integration is complete, and momentum is expected to be maintained through H2. The worst is definitively behind the existing facilities, though any new facilities will carry their own ramp-up curves.
• PAT target set: management aims for close to 5% PAT once optimum levels are reached, and expects that to happen "sooner than later."
• Capital allocation conviction: the company continues to allocate capital to the shoe business, signaling confidence in growth beyond the current recovery.
• Revenue doubling question deflected: when asked if shoe revenue could double in FY27 given the INR140 crore gross block and current asset turns, management declined to give an exact number, citing the need for new people, training, and ramp-up for any new factories.

Sameer Kothari: "We continue to be extremely confident and optimistic about this business, not only in terms of what we are currently doing, but also in terms of growth and which is why if you look at the capex, capital allocation, we continue to allocate capital to this business because we are confident that we'll be able to grow this further."

Capex: Faster, Larger, and Partly Invisible in Revenue

• H1 capacity additions: nearly INR200 crores worth of new capacity was commercialized, with another INR550 crores-plus advancing toward commissioning in the next couple of quarters.
• Two acquisitions accelerated the pace: a cone manufacturing facility (approximately INR30 crores) as backward integration for the ice cream vertical, and a Home and Personal Care facility (approximately INR40 crores), both announced recently and earlier than originally projected.
• The revenue-capex disconnect is structural, not a warning: many large contracts with multinational beverage and ice cream clients operate on a job-work basis where the client supplies raw and packing material, so only conversion costs book as revenue. EBITDA and PAT grow in sync with capex, subject to commissioning time lags, but top-line growth will trail.
• Agricultural commodity deflation compounded the optics: a roughly 20% decline in agricultural commodity prices over the last year further suppressed reported top-line growth.
• Funding is secured: all incremental capex, including the INR550 crores pipeline, will be funded through a mix of internal accruals and prudent debt, with Board approval for a 1:1 debt-equity ratio.
• FY27 capex guidance withheld: management said it is not in a position to give tangible FY27 capex numbers yet, citing a pipeline that includes both organic and inorganic opportunities, and promised a better timeline next quarter.

Sameer Kothari: "I think any business should be evaluated only on the basis of PAT and not on anything else."

Ice Cream: Backward Integration and Capacity Build-Out

• Cone and sticks acquisition is strategic, not just financial: the recently announced cone manufacturing plant, alongside an existing sticks plant, opens a large part of the ice cream value chain and symbolizes the deliberate shift from dedicated manufacturing toward more integrated, shared-manufacturing business models.
• Capacity ramp-up on track: the Sandila facility is already working at full capacity across all ice cream formats. The Nashik factory stabilized production in its first operational season and is expected to reach full capacity by Q3 end and through Q4.
• Panipat facility timeline: commercial production is expected to begin by Q4 of this financial year, with full capacity ramp-up by Q1 of the next financial year.
• GST catalyst awaited: management is keenly awaiting the fallout of GST rationalization on ice creams, believing a lower rate will increase consumption. No specific timeline was given for when the benefit will trickle down.

Sameer Kothari: "More than the number of INR60 crores, I think what's more important is that from the nature of the business perspective, it's symbolic of what we are trying to do. The shift from dedicated manufacturing to these kind of business models is what I would urge your attention to."

Shared Manufacturing: The Deliberate Model Shift

• The shift is intentional, not accidental: over the last four years, the company has increased its exposure to shared manufacturing from a base of predominantly dedicated manufacturing, which had assured consistent fixed returns. The move is a response to the changing FMCG ecosystem and is designed to unlock operating leverage across factories.
• No red line on the mix: management declined to set an internal limit on shared versus dedicated capacity, calling the mix a dynamic response to customer needs rather than a target to be managed to a ratio.
• The trade-off is real: in shared manufacturing, operating leverage sits entirely with the company. Last year's losses in the shoe business were a direct consequence, and the caution was reiterated: return ratios should improve as shared manufacturing scales, but the path carries execution risk.
• Return ratios are optically depressed: cash currently sitting in the bank makes ROE and ROCE look lower than underlying economics suggest. As that cash is invested into return-generating assets, ratios are expected to come in line with expectations.

Mayank Samdani: "Your understanding is correct. But I will put a caution to this that as we move towards the more shared manufacturing, the operating leverage is entirely upon us. As we have seen last year in the shoes business, we have suffered some losses in it."

Growth Outlook and the Missing Multi-Year Plan

• Top-line growth endeavor: management aims to compound the top line at 20-25% with current categories for at least the foreseeable future, and believes the company should be shielded from macro slowdown. When pressed to confirm the 20-25% figure as a target, the response was "that's the endeavour" rather than a firm commitment.
• Macro tailwinds cited: GST rationalization, income tax cuts, interest rate reductions, and falling inflation are all expected to provide higher growth impetus. GST changes in particular are expected to benefit most business verticals by shifting demand from unorganized to organized players.
• A quantified multi-year plan was requested but not delivered: an analyst asked for a 2-3 year road map across categories, growth rates, return ratios, and cash flow generation. Management said they are working on it and will come back with a definite plan "maybe early next year," offering only a high-level view that all categories have potential to grow manifold times.
• Revenue and margin guidance explicitly declined: management stated they cannot give revenue guidance or margin guidance, and that the only guidance provided is on gross blocks and what the business is doing.
• Quick commerce as an emerging channel: the company has gained a foothold with newer brands, is increasing wallet share with traditional incumbents, and is working with channel players as the FMCG ecosystem evolves.
• OTC healthcare is a hidden pipeline: the vertical has done well but is not yet visible in financials due to long gestation periods. New customers have been signed, but a 6-8 month gap exists before delivery starts after validation trials.

Guidance & Commitments

Key Metrics